affiliation not provided to SSRN
SARS-CoV-2 vaccines, breakthrough SARS-CoV-2 infection, correlates of protection, hematological malignancies, allogeneic stem cell transplantation, autologous stem cell transplantation, COVID-19, vaccine, immunocompromised patients, Moderna mRNA-1273, Pfiz
SARS-CoV-2, COVID-19 vaccine, T-cell immunity, anti-RBD antibodies, booster